Impact of Inflammation-Metaplasia-Adenocarcinoma Sequence and Prevention in Surgical Rat Models
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The incidence of esophageal cancer continues to rise in the Western world. Prior studies have suggested that gastroduodenal content reflux from gastroesophageal reflux disease induces the inflammation-mediated progression from hyperplasia to metaplasia, and to adenocarcinoma. We further investigated the sequential development of esophageal adenocarcinoma (EADC) with the use of an established surgical rat model. The present paper will describe the impact of the inflammation-metaplasia-adenocarcinoma sequence and chemoprevention in surgical rat models. A clinically relevant rat reflux model was used to investigate the cause of carcinogenesis, the sequential development of adenocarcinoma and chemoprevention with the use of a proton pump inhibitor. We found that duodenal reflux plays an important role in the inflammation-induced transformation of esophageal mucosa to adenocarcinoma. We were able to inhibit this transformation with rabeprazole, a proton pump inhibitor. Duodenal reflux promotes inflammation in the esophagus. The inflammation-metaplasia-adenocarcinoma sequence is important in the progression and development of EADC. Carcinogenesis can be prevented with chemoprevention agents such as rabeprazole. These results will need to be validated in clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to a recent study, gastric acid is a strong activator a number of autoprotective mechanisms, including proliferation and differentiation, as well as the production of anti-inflammatory cytokines, growth factors and endogenous antioxidants [4], [11], [12].”
From Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis (2014) · cites this paper as [12]
In the citing paper
“These changes are attributed to proliferation and transformation of the normal squamous epithelium of the esophagus into gastric-type mucosa, a pre-malignant condition [12].”
From Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis (2014) · cites this paper as [12]
Citations
Cites
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1998) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.1.6 · Cited by 2,341
Dichotomy of astrocytoma migration and proliferation
Giese, A., Loo, M. A., Tran, N., Haskett, D., Coons, S. W., & Berens, M. E. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960717)67:2<275::aid-ijc20>3.0.co;2-9 · Cited by 399
Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
Hillman, L. C., Chiragakis, L., Kaye, G. L., Clarke, A. C., & Shadbolt, B. (2004) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05991.x · Cited by 195
Acid, Bile, and CDX: the ABCs of making Barrett's metaplasia
Souza, R. F., Krishnan, K., & Spechler, S. J. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90250.2008 · Cited by 187
Aberrant Epithelial–Mesenchymal Hedgehog Signaling Characterizes Barrett's Metaplasia
Wang, D. H., Clemons, N. J., Miyashita, T., Dupuy, A. J., Zhang, W., Szczepny, A., Corcoran–Schwartz, I. M., Wilburn, D. L., Montgomery, E. A., Wang, J. S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.048 · Cited by 184
Self-citationReflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats
Miwa, K., Sahara, H., Segawa, M., Kinami, S., Sato, T., Miyazaki, I., & Hattori, T. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960717)67:2<269::aid-ijc19>3.0.co;2-6 · Cited by 184
Self-citationKazumori, H. (2006) · Gut · doi:10.1136/gut.2005.066209 · Cited by 183
CpG island hypermethylation in progression of esophageal and gastric cancer
Sato, F., & Meltzer, S. J. (2005) · Cancer · doi:10.1002/cncr.21657 · Cited by 143
Research works printed but not linked: 1
- 10.1093%2fcarcin%2f21.8.1587 · doi:10.1093/carcin/21.8.1587
Cited by
Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma
Zaidi, A. H., Kelly, L. A., Kreft, R. E., Barlek, M., Omstead, A. N., Matsui, D., Boyd, N. H., Gazarik, K. E., Heit, M. I., Nistico, L., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2093-8 · Cited by 95
Miyashita, T., Tajima, H., Shah, F. A., Oshima, M., Makino, I., Nakagawara, H., Kitagawa, H., Fujimura, T., Harmon, J. W., & Ohta, T. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3537-5 · Cited by 42
Self-citationZaidi, A. H., Kosovec, J. E., Matsui, D., Omstead, A. N., Raj, M. S., Rao, R. R., Biederman, R. W., Finley, G. G., Landreneau, R. J., Kelly, R. J., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001908 · Cited by 37
Cytoprotective Effects of Hydrogen Sulfide in Novel Rat Models of Non-Erosive Esophagitis
Zayachkivska, O., Havryluk, O., Hrycevych, N., Bula, N., Grushka, O., & Wallace, J. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110688 · Cited by 34
“According to a recent study, gastric acid is a strong activator a number of autoprotective mechanisms, including proliferation and differentiation, as well as the production of anti-inflammatory cytokines, growth factors and endogenous antioxidants [4,11,12].”
BackgroundClinical Impact of Tumor-Infiltrating Inflammatory Cells in Primary Small Cell Esophageal Carcinoma
Zhang, Y., Ren, H., Wang, L., Ning, Z., Zhuang, Y.-X., Gan, J., Chen, S., Zhou, D., Zhu, H., Tan, D., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069718 · Cited by 34
“inflammation was observed in human esophageal cancers [5,8,20,21], animal models of esophageal cancer [22], and esophageal cancer cell lines [23], and this inflammation plays a role in the carcinogenesis of esophageal tumors [5,20,21,24].”
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma
Kosovec, J. E., Zaidi, A. H., Kelly, L. A., Rotoloni, C. L., Vytlacil, C., DiCarlo, C. M., Matsui, D., Komatsu, Y., Boyd, N. H., Omstead, A. N., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001467 · Cited by 20
Leptin activates Akt in oesophageal cancer cells via multiple atorvastatin-sensitive small GTPases
Beales, I., & Ogunwobi, O. O. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04067-8 · Cited by 15
Zaidi, A. H., Saldin, L. T., Kelly, L. A., Bergal, L., Londoño, R., Kosovec, J. E., Komatsu, Y., Kasi, P. M., Shetty, A., Keane, T. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122375 · Cited by 12
Miyashita, T., Kono, T., Matsui, D., Yamazaki, Y., Sadatomi, D., Fujitsuka, N., Nakanuma, S., Okamoto, K., Makino, I., Kinoshita, J., et al. (2018) · Surgery · doi:10.1016/j.surg.2018.02.003 · Cited by 11
Self-citationPathophysiology of Barrett's Esophagus-Associated Neoplasia: Circumferential Spatial Predilection
Ishimura, N., Okada, M., Mikami, H., Okimoto, E., Fukuda, N., Uno, G., Aimi, M., Oshima, N., Ishihara, S., & Kinoshita, Y. (2014) · Digestion · doi:10.1159/000365123 · Cited by 8
Sadatomi, D., Kono, T., Mogami, S., & Fujitsuka, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-77495-z · Cited by 8
Pandiar, D., & Krishnan, R. P. (2024) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_145_24 · Cited by 5
“[17] As aforementioned and described in the literature, chronic inflammation could lead to metaplastic changes in the epithelial lining.”
Miida, H., Wakaki, K., & 下田, 聡. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14506 · Cited by 4
International Journal of Cancer Research and Treatment
Karger, S. (2015) · Cited by 4
Han, Y., Park, J., Lee, H.-J., Kim, E., & Hahm, K. B. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.4.289 · Cited by 2
Extracellular Nucleic Acids and Cancer
Fleischhacker, M., & Schmidt, B. (2014) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-017-9168-7_10 · Cited by 2
INFECTION CONTROL TO AVOID SURGICAL SITE INFECTION
ABOU-HATAB, M., & El-Bahnasawy, M. M. M. (2013) · Journal of the Egyptian Society of Parasitology · doi:10.21608/jesp.2013.94813 · Cited by 1
Metadata
- Authors
- Miyashita, T., Shah, F. A., Miwa, K., Sasaki, S., Nishijima, K., Oyama, K., Ninomiya, I., Fushida, S., Fujimura, T., Hattori, T., Harmon, J. W., & Ohta, T.
- Affiliations
- Kanazawa University Hospital (JP)
- Johns Hopkins University (US)
- Houju Memorial Hospital (JP)
- Shiga University of Medical Science (JP)
- ORCID
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 87
- Issue
- 1
- Pages
- 6-11
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W2025384451
- Cited by
- 16
- References
- 22
- Citations by year
- 2024: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 2 · 2015: 3 · 2014: 5 · 2013: 1
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Digestion (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Surgery › Esophageal and GI Pathology
- Keywords
- esophageal adenocarcinoma, gastroesophageal reflux disease, bile reflux, esophageal inflammation, metaplasia, chemoprevention, rabeprazole, proton pump inhibitors, carcinogenesis
- MeSH terms
- Adenocarcinoma, Animals, Disease Models, Animal, Duodenum, Epithelium, Esophageal Neoplasms, Esophagus, Metaplasia, Disease Progression, Rats, 2-Pyridinylmethylsulfinylbenzimidazoles, Proton Pump Inhibitors, Rabeprazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.